Discovery of substituted (4-phenyl-1H-imidazol-2-yl)methanamine as potent somatostatin receptor 3 agonists

Bioorg Med Chem Lett. 2015 Sep 1;25(17):3520-5. doi: 10.1016/j.bmcl.2015.06.087. Epub 2015 Jul 4.

Abstract

We report SAR studies on a novel non-peptidic somatostatin receptor 3 (SSTR3) agonist lead series derived from (4-phenyl-1H-imidazol-2-yl)methanamine. This effort led to the discovery of a highly potent low molecular weight SSTR3 agonist 5c (EC50=5.2 nM, MW=359). The results from molecular overlays of 5c onto the L-129 structure indicate good alignment, and two main differences of the proposed overlays of the antagonist MK-4256 onto the conformation of 5c lead to inversion of antagonism to agonism.

Keywords: (4-Phenyl-1H-imidazol-2-yl)methanamine; Somatostatin receptor 3 (SSTR3) agonist; Structural overlay.

MeSH terms

  • Drug Discovery
  • Humans
  • Methylamines / chemistry*
  • Receptors, Somatostatin / chemistry*
  • Structure-Activity Relationship

Substances

  • Methylamines
  • Receptors, Somatostatin
  • somatostatin receptor 3
  • methylamine